Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea · Delayed Price · Currency is KRW 59,500
+3,900 (7.01%)
Jun 29, 2026, 1:50 PM KST
Mezzion Pharma Market Cap
Mezzion Pharma has a market cap or net worth of 1.69 trillion as of June 26, 2026. Its market cap has increased by 40.43% in one year.
Market Cap
1.69T
Enterprise Value
1.68T
Revenue
7.97B
Ranking
n/a
PE Ratio
n/a
Stock Price
59,500.00
Market Cap Chart
Since January 20, 2012, Mezzion Pharma's market cap has increased from 240.02B to 1.69T, an increase of 604.02%. That is a compound annual growth rate of 14.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 1.69T | -38.23% |
| Dec 30, 2025 | 2.74T | 195.96% |
| Dec 30, 2024 | 924.37B | -19.89% |
| Dec 28, 2023 | 1.15T | 231.92% |
| Dec 29, 2022 | 347.65B | -82.01% |
| Dec 30, 2021 | 1.93T | 23.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.16T |
| Celltrion | 36.46T |
| ALTEOGEN | 20.09T |
| Samsung Epis Holdings | 10.61T |
| Hanmi Science | 1.85T |
| Celltrion Pharm | 1.74T |
| GC Biopharma | 1.35T |
| Oscotec | 1.34T |